The Assessment of the Symptoms of Premenstrual Syndrome and their Response to Therapy (original) (raw)
Related papers
Gynecological Endocrinology, 2007
Premenstrual syndrome (PMS) encompasses a variety of symptoms appearing during the luteal phase of the menstrual cycle. Although PMS is widely recognized, the etiology remains unclear and it lacks definitive, universally accepted diagnostic criteria. To address these issues an international multidisciplinary group of experts evaluated the current definitions and diagnostic criteria of PMS and premenstrual dysphoric disorder (PMDD). Following extensive correspondence, a consensus meeting was held with the aim of producing updated diagnostic criteria for PMS and guidelines for clinical and research applications. This report presents the conclusions and recommendations of the group. It is hoped that the criteria proposed by the group will become widely accepted and eventually be incorporated into the next edition of the World Health Organization's International Classification of Diseases (ICD-11). It is also hoped that the proposed guidelines for quantification of criteria will be used by clinicians and investigators to facilitate diagnostic uniformity in the field as well as adequate treatment modalities when warranted.
BJOG: An International Journal of Obstetrics and Gynaecology, 1994
Objective To demonstrate similarities and differences between the various instruments used by clinical trialists for measurement of premenstrual syndrome to encourage development of consensus of measurement to aid future research. Design Computer and manual searches of all trials of drugs used for premenstrual syndrome supplemented by retrieval of all questionnaires and scales cited. Letters were sent to the main manufacturers to identify trials not in the public domain.
Revista Brasileira de Ginecologia e ObstetrÃcia / RBGO Gynecology and Obstetrics
Objective To validate the premenstrual symptoms screening tool (PSST) in relation to the daily record of severity of problems (DRSP) for premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) diagnoses. Methods A cross-sectional study with 127 women (20–45 years) with PMS complaints. The women were evaluated in terms of weight, height and body mass index (BMI). After using the primary care evaluation of mental disorders (PRIME-MD) questionnaire to exclude the diagnosis of depression, the PSST was completed and the women were instructed to fill out the DRSP for two consecutive menstrual cycles. The agreement between the two questionnaires was assessed by the Kappa (k) and the prevalence-adjusted, bias-adjusted kappa (PABAK) values. Results Two-hundred and eighty-two women met the eligibility criteria and answered the PSST. The DRSP was completed for two cycles by 127 women. The percentages of women with PMS and PMDD diagnoses by the DRSP were 74.8% and 3.9% respective...
Journal of Advanced Nursing, 1991
Symptom patterns in women with Premenstrual Sjmdrome complainfe: a prospective assessment using a marker for ovulation and screening criteria for adequate ovarian function This study exammed the symtom pattems of women seekmg help for Premenstrual Syndrome (PMS) complamts Seven women who were less than 35 yrs, withm 10% of ideal body weight and who had expenenced a full-term pregnancy, completed a daily health diary dunng an ovulatory menstrual cyde In the luteal phase, symptom sununary scores of the PMS group mcreased (P < 0 05) and were markedly higher (P < 0 5) fi-om baselme acychc scores of four ovulatory women who demed menstrual-related distress To examme seventy changes m mdividual symptoms, a total of 399 cases represenhng 57 symptoms from the seven 45-day dianes were evaluated for menstrual cyde entrainment Of the 246 symptoms that met the cntena for a cycle phase change (62%), the dassic PMS pattem of low/high seventy was the most common (40%) Seven different subtypes of the PMS pattem were identified, four of these subtypes demonstrated a seventy score elevation at ovulahon as well as dunng the premenstruum For mdividual women, the majonty of symptoms (65%) displayed only two pattem types, suggesting a common rhythmic entrainment of symptom mtensity
The biomedical standardization of premenstrual syndrome
Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 2008
This essay traces the history of premenstrual syndrome (PMS) in French, British, and American medical literature from 1950 to 2004. Aetiological theories, treatments and diagnostic criteria have varied over time and place, reflecting local conditions and changing notions of objectivity and evidence. During the 1970s researchers in each nation utilised different research strategies to overcome variation and contradictory results characteristic of PMS research. Since the 1980s, attempts have been made to standardise research internationally through prospective daily rating questionnaires that diagnose and measure PMS. Amidst controversy, a psychiatric reformulation of the syndrome was included in the Diagnostic and Statistical Manual of Mental Disorders (DSM). While the diagnostic criteria for this psychiatric category, now called premenstrual dysphoric disorder (PMDD), are widely accepted for research purposes, efforts to transfer them to medical practice have been less successful. PMDD remains a contested disease construct.
Assessment of premenstrual symptomatology: a re-evaluation of the predictive validity of self-report
Journal of Psychosomatic Research, 1988
The predlctlve vahdlty of subjects' self-reports of the severity of four groups of symptoms associated with the premenstrual syndrome (PMS) was assessed by canomcal correlation of retrospective self-reports of usual symptom seventles with prospectively obtamed symptom seventy scores from the next two cycles Prospective scores from the second cycle were then correlated with retrospective recall scores obtained after the end of that cycle A measure of inter-cycle vanabIlity was obtamed by correlation between two consecutive sets of prospective scores The symptoms studied were tenslon, depresslon, cogmtlve and physical ('water retention') symptoms It was found that subjects' recall of a particular cycle predicted 72% of the variance m that cycle's prospective seventy scores, mdlcatmg that the subjects correctly interpreted the seventy of premenstrual symptoms and dlstmgulshed them from symptoms present m the folhcular part of the cycle Retrospective reports of usual PMS symptomatology predlcted 21% of the vanance m symptom scores m the next menstrual cycle and 12% of the variance m the followmg one Despite this decrease, averaging the scores from the two prospective cycles improved the predIction to 23% Prospective scores from one cycle predicted only 14% of the vanance m prospectlve scores from the next, suggesting a high degree of inter-cycle vanablhty Women's self-reports of their usual PMS symptomatology reflect their expenence more accurately than has been thought The fmdmg of marked inter-cycle vdrlabdity suggests that arguments for the use of a single cycle of prospective data m PMS evaluation are fallacious and that retrospective self-report may be chmcally useful and relatively vahd
Journal of Psychosomatic Research, 1993
The topic of a single vs multiple premenstrual syndromes has generated much discussion. In this study, multivariate profile analysis was used to determine whether or not physical and affective symptoms associated with the premenstrual syndrome (PMS) could be explained as the manifestation of one underlying pathophysiologic process. The premenstrual symptom profiles of 820 undergraduate students and 485 graduate students were evaluated. It was not possible to reject the null hypothesis of parallel profiles in most comparisons, suggesting that variability in the severity of premenstrual symptoms may be the result of individual differences in the expression of one underlying pathophysiologic process.
The measurement of premenstrual mood symptoms
Journal of Affective Disorders, 1999
Introduction: To aid in the diagnosis and management of premenstrual syndromes, dozens of symptom measurement instruments have been created and several methods for classifying clinically important change in symptoms have been defined. While the diagnosis of premenstrual dysphoric disorder (PMDD) has become standardized through the application of research criteria, consensus amongst investigators as to the instruments best able to confirm the diagnosis and measure treatment effects has yet to be reached. Objective: To determine the performance and inter-correlations of three prospective symptom rating scales used to establish severity of premenstrual mood symptoms and measure efficacy during a treatment trial for premenstrual dysphoria. Methods: Single item visual analogue scales (VASs) for irritability, tension, depression and mood swings were used in combination with the Premenstrual Tension Syndrome Observer (PMTS-O) and Self-Rating (PMTS-SR) scales to measure the severity of premenstrual mood symptoms at baseline and during treatment. Results: Premenstrual mood symptoms as measured by VASs significantly correlated with PMTS-0 and PMTS-SR scale scores (range 0.70 to 0.82, P , 0.001). All scales were sensitive to premenstrual symptom worsening (which is a required characteristic of this disorder) and revealed differences in effects of treatment on premenstrual mood symptoms (P , 0.001). Conclusions: VASs in combination with the PMTS-O are low in burden to the client, reliable, valid and sensitive to change. In light of the current debates regarding instruments most appropriate for the classification and measurement of treatment effects in women diagnosed with premenstrual dysphoria, further refinement of these scales is warranted.
Diagnosis, pathophysiology and management of premenstrual syndrome
The Obstetrician & Gynaecologist, 2015
An overview of current information available on premenstrual syndrome (PMS), which is in accordance with the new RCOG Green-top Guideline. Definition of PMS and explanation about the different types of premenstrual disorders. How to accurately diagnose PMS. Discussion about various treatment options available in accordance with the current literature. Learning objectives Develop an understanding of the pathophysiology behind PMS. How to diagnose PMS accurately and understand the different classifications of PMS. How to treat PMS, including the different treatment options available and discussion about side effects and benefits. Ethical issues Discussion about the long-term risks of GnRH analogue use, and the impact of long-term estrogen deficiency following a bilateral salpingoophorectomy. Misdiagnosed PMS in patients with underlying psychiatric and medical conditions.